Navigation Links
Microtainer Genie Lancet

ProductsMicrotainer Genie Lancet
Company BD Diagnostic Systems
Item Microtainer Genie Lancet
Features 
  • Convenient, self-contained, single-use device with no loading or special preparation required.
  • Full range of blade depths and needle gauges optimizes blood flow for varying sample requirements.
  • Purple BD Microtainer Genie is the smallest gauge, single-use, glucose lancet available.
  • Low trigger force makes device easier to activate.
  • Ultra-sharp surgical stainless-steel blades and needles allow for exceptional patient comfort.
  • A one-step activation, within milliseconds, ensures a rapid, precise incision that is consistent in depth and width.
  • Automatic and permanent lancet retraction minimizes possible injury and eliminates accidental reuse.
Description Maximize blood flow while minimizing the pain of a finger stick with the safety-engineered BD Microtainer Genie Lancet. The BD Microtainer Genie Lancet offers a full range of blades and needles for capillary blood collection and protects the healthcare worker with permanently retractable technology.
Info BD Diagnostic Systems
Customer Service: (800) 675-0908
Web site: http://www.bd.com/ds/

Related medicine products :

1. Microtainer Quikheel Lancet
2. BD Microtainer Blood Collection Tubes
3. Genie Pro
4. Roto-Shake Genie
5. Roto-Shake Genie, 240V
6. Vortex Adapter for Vortex Genie 2, holds (12) 2 ml tubes
7. Vortex Adapter for Vortex Genie 2, holds (2) 50 ml tubes
8. Vortex Adapter for Vortex Genie 2, holds (4) 15 ml tubes
9. Vortex Genie 2
10. Vortex Adapter, Genie 2, 24 ml tubes
11. Vortex Genie 2 (220V)
Breaking Medicine Technology:ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 3ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6Lack of happiness hormone serotonin in the brain causes impaired maternal behavior in mice 8972 1Energy saving method checks refrigerant level in air conditioners 8970 1Energy saving method checks refrigerant level in air conditioners 8970 2How to text message and avoid pain 8968 1How to text message and avoid pain 8968 2